Gut microbiota in alcoholic liver disease: Pathogenetic role and therapeutic perspectives

Aldehyde dehydrogenase 2 deficiency ameliorates alcoholic fatty liver but worsens liver inflammation and fibrosis in mice

(2014) Hyo-Jung Kwon et al.   HEPATOLOGY

Role of the intestinal microbiome in liver disease

(2013) Jorge Henao-Mejia et al.   JOURNAL OF AUTOIMMUNITY

Metagenomic Analyses of Alcohol Induced Pathogenic Alterations in the Intestinal Microbiome and the Effect of Lactobacillus rhamnosus GG Treatment

(2013) Lara Bull-Otterson et al.   PLoS One

Gastrointestinal bacterial overgrowth: pathogenesis and clinical significance

(2013) Amit H. Sachdev et al.   Therapeutic Advances in Chronic Disease

Colonic microbiome is altered in alcoholism

(2012) Ece A. Mutlu et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: A connection between endogenous alcohol and NASH

(2012) Lixin Zhu et al.   HEPATOLOGY

Bacterial translocation and changes in the intestinal microbiome in mouse models of liver disease

(2012) Derrick E. Fouts et al.   JOURNAL OF HEPATOLOGY

Gut–liver axis: The impact of gut microbiota on non alcoholic fatty liver disease

(2012) D. Compare et al.   NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES

Host-Gut Microbiota Metabolic Interactions

(2012) J. K. Nicholson et al.   SCIENCE

Toll-Like Receptor 4 Mediates Alcohol-Induced Steatohepatitis Through Bone Marrow-Derived and Endogenous Liver Cells in Mice

(2011) Sayaka Inokuchi et al.   ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH

Bifidobacterium longum with Fructo-Oligosaccharides in Patients with Non Alcoholic Steatohepatitis

(2011) Michele Malaguarnera et al.   DIGESTIVE DISEASES AND SCIENCES

S-adenosylmethionine prevents the up regulation of Toll-like receptor (TLR) signaling caused by chronic ethanol feeding in rats

(2011) Joan Oliva et al.   EXPERIMENTAL AND MOLECULAR PATHOLOGY

Alcoholic Liver Disease: Pathogenesis and New Therapeutic Targets

(2011) Bin Gao et al.   GASTROENTEROLOGY

Probiotics in the gastrointestinal diseases of the elderly

(2011) G. Malaguarnera et al.   Journal of Nutrition Health & Aging

Role of innate immunity and the microbiota in liver fibrosis: crosstalk between the liver and gut

(2011) Ekihiro Seki et al.   JOURNAL OF PHYSIOLOGY-LONDON

Rifaximin - ein nicht resorbierbares Antibiotikum mit vielfältigen Anwendungsmöglichkeiten in der Gastroenterologie

(2011) T. Rabenstein et al.   ZEITSCHRIFT FUR GASTROENTEROLOGIE

Mechanisms and cell signaling in alcoholic liver disease

(2010) Juliane I. Beier et al.   BIOLOGICAL CHEMISTRY

Gut microbiota and probiotics in chronic liver diseases

(2010) Claudia Cesaro et al.   DIGESTIVE AND LIVER DISEASE

Bifidobacterium combined with fructo-oligosaccharide versus lactulose in the treatment of patients with hepatic encephalopathy

(2010) Mariano Malaguarnera et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Enteric dysbiosis associated with a mouse model of alcoholic liver disease

(2010) Arthur W. Yan et al.   HEPATOLOGY

Small Intestinal Bacterial Overgrowth

(2010) Eamonn M.M. Quigley et al.   INFECTIOUS DISEASE CLINICS OF NORTH AMERICA

Rifaximin Treatment in Hepatic Encephalopathy

(2010) Nathan M. Bass et al.   NEW ENGLAND JOURNAL OF MEDICINE

Gastrointestinal Alcohol Dehydrogenase

(2010) Helmut K. Seitz et al.   NUTRITION REVIEWS

Probiotics and gut health: A special focus on liver diseases

(2010) Silvia Wilson Gratz   WORLD JOURNAL OF GASTROENTEROLOGY

Current and Emerging Strategies for Treating Hepatic Encephalopathy

(2010) Keith J. Foster et al.   Critical Care Nursing Clinics of North America

Treatment of alcoholic liver disease

(2010) Thomas H. Frazier et al.   Therapeutic Advances in Gastroenterology

Lactobacillus GG treatment ameliorates alcohol-induced intestinal oxidative stress, gut leakiness, and liver injury in a rat model of alcoholic steatohepatitis

(2009) Christopher B. Forsyth et al.   ALCOHOL

Role of SIRT1 in regulation of LPS- or two ethanol metabolites-induced TNF-α production in cultured macrophage cell lines

(2009) Zheng Shen et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

Gastrointestinal microbiology enters the metagenomics era

(2009) Daniel N Frank et al.   CURRENT OPINION IN GASTROENTEROLOGY

Rifaximin: a unique gastrointestinal-selective antibiotic for enteric diseases

(2009) Hoonmo L Koo et al.   CURRENT OPINION IN GASTROENTEROLOGY

Toll-like receptor agonists in cancer therapy

(2009) Sylvia Adams   Immunotherapy

Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders

(2009) Jürgen Rehm et al.   LANCET

Alcohol, intestinal bacterial growth, intestinal permeability to endotoxin, and medical consequences: Summary of a symposium

(2008) Vishnudutt Purohit et al.   ALCOHOL

Genomics Can Advance The Potential For Probiotic Cultures To Improve Liver And Overall Health

(2008) Daniel O'Sullivan   CURRENT PHARMACEUTICAL DESIGN

Microbes in Gastrointestinal Health and Disease

(2008) Andrew S. Neish   GASTROENTEROLOGY

Lactobacillus rhamnosus Strain GG Prevents Enterohemorrhagic Escherichia coli O157:H7-Induced Changes in Epithelial Barrier Function

(2008) K. C. Johnson-Henry et al.   INFECTION AND IMMUNITY

Prebiotics as Gut Microflora Management Tools

(2008) Glenn R. Gibson   JOURNAL OF CLINICAL GASTROENTEROLOGY

Antibiotics protect against fructose-induced hepatic lipid accumulation in mice: Role of endotoxin

(2008) Ina Bergheim et al.   JOURNAL OF HEPATOLOGY